Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor, RNA polymerase I subunit B (TAF1B), is a protein component of the transcription factor SL1, which is essential for the initiation of transcription by RNA polymerase I. SL1, a complex composed of TATA-binding protein (TBP) and three TBP-associated factors (TAFs), binds to the rDNA core promoter and positions RNA polymerase I for rRNA gene transcription. TAF1B acts as a GTF2B/TFIIB-like factor, participating in pre-initiation complex assembly and facilitating recruitment and regulation of RNA polymerase I, possibly by direct interaction with transcription factors such as RRN3. Evidence for TAF1B's direct role as a therapeutic target or drug-interaction partner is currently lacking[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor, RNA polymerase I subunit B (TAF1B).